Showing results (1501-1510 of 1,711) with videos related to

Sort By:
Pageof 172
Nature Communications|September 5, 2020
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main proteaseLifeng Fu, Fei Ye, Yong Feng, et al.
Cancer Letters|December 17, 2014
Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinomaWen-Ting Liu, Ying-Ying Jing, Guo-Feng Yu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2022
Association of Fruit, Vegetable, and Animal Food Intakes with Breast Cancer Risk Overall and by Molecular Subtype among Vietnamese WomenSang M Nguyen, Huong T T Tran, Lan M Nguyen, et al.
American Journal of Cancer Research|June 25, 2014
Protein signature for non-small cell lung cancer prognosisWei Liu, Yong Wu, Libo Wang, et al.
Scientific Reports|April 7, 2024
Systematic analyses of the factors influencing sperm quality in patients with SARS-CoV-2 infectionGuohui Zhang, Weiwei Zhi, Fei Ye, et al.
Trials|August 29, 2021
2-Hydroxybenzylamine (2-HOBA) to prevent early recurrence of atrial fibrillation after catheter ablation: protocol for a randomized controlled trial including detection of AF using a wearable deviceMatthew J O'Neill, Zachary T Yoneda, Diane M Crawford, et al.
BMC Genomics|September 25, 2015
Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromesYan Guo, Amma Bosompem, Sanjay Mohan, et al.
Journal of Interventional Cardiology|July 21, 2010
Contradictory shear stress distribution prevents restenosis after provisional stenting for bifurcation lesionsJun-Jie Zhang, June-Jie Zhang, Shao-Liang Chen, et al.
Plos One|October 25, 2013
Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancerXinyu Wu, Yirong Li, Jinhua Wang, et al.
Scientific Reports|April 3, 2023
Morphologies and composition changes in nonculprit subclinical atherosclerosis in diabetic versus nondiabetic patients with acute coronary syndrome who underwent long-term statin therapyPei-Na Meng, Jia-Cong Nong, Yi Xu, et al.
Pageof 172